# The Late Presenter Treatment Optimisation Study

> **NCT03696160** · PHASE3 · COMPLETED · sponsor: **NEAT ID Foundation** · enrollment: 447 (actual)

## Conditions studied

- HIV/AIDS

## Interventions

- **DRUG:** Biktarvy
- **DRUG:** Symtuza

## Key facts

- **NCT ID:** NCT03696160
- **Lead sponsor:** NEAT ID Foundation
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-05
- **Primary completion:** 2024-06-17
- **Final completion:** 2024-06-17
- **Target enrollment:** 447 (ACTUAL)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03696160

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03696160, "The Late Presenter Treatment Optimisation Study". Retrieved via AI Analytics 2026-07-29 from https://api.ai-analytics.org/clinical/NCT03696160. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*